IMMUNE checkpoint inhibitor (ICI)-based therapy before liver transplantation may improve survival and reduce cancer recurrence in patients with hepatocellular carcinoma (HCC), according to a multicentre study involving 416 transplant recipients. …
Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.
Copyright ©️ 2026 Daily Transplant News | All rights reserved.
